Dr. Farah H. Mahmood, MD

Dr. Mahmood practices at Prohealth Partners a Medical Group in Foothill Ranch, California.

Dr. Mahmood's NPI, 1134385974, was assigned on July 31, 2008. Dr. Mahmood graduated from Rawalpindi Medical College in 1999. Dr. Mahmood holds California license A106661.

Dr. Mahmood's primary practice is Prohealth Partners a Medical Group, at 26700 Towne Centre Dr, Foothill Ranch, CA 92610 in Orange County. The practice phone is (949) 519-0020.

Dr. Mahmood's primary practice is Prohealth Partners a Medical Group in Foothill Ranch, California. Dr. Mahmood is also affiliated with Hoag Hospital Newport Beach. The medical group on file is ProHealth Partners. Dmand AI also links Dr. Mahmood to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mahmood practices, 3 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Mahmood's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Mahmood is board certified in rheumatology by the American Board of Internal Medicine. Dmand AI has Dr. Mahmood's licenses on file in 3 states: California, Missouri and Mississippi.

Dmand AI lists arteritis, fluid in a joint, gout, joint arthropathy, joint pain, lupus, muscle pain, fibromyalgia, and limb pain and osteoporosis among the conditions Dr. Mahmood treats.

CMS data shows 391 Medicare services from Dr. Mahmood across 4 procedure codes in 2024, for 115 Medicare patients. Medicare paid $37,030 for them. Every service was in an office.

CMS counts 115 Medicare patients who saw Dr. Mahmood in 2024. The largest group is 65 to 74, with 76 patients. 75% of them have arthritis, and 75% have high cholesterol. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mahmood's median patient age at 67, with 73% women.

In 2024, Dr. Mahmood wrote 1,951 Medicare Part D claims for 323 patients. 75% of them were for generic drugs. CMS names the drug for 1,835 of them, across 28 drugs with 11 or more claims each, at $2,267,425 in total drug cost. In 2023, CMS named 1,545 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 39 out of 100 for Dr. Mahmood for performance year 2024, reported as part of a group. Dr. Mahmood accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mahmood as offering telehealth.

Dmand AI links 8 papers to Dr. Mahmood, published from 2022 to 2025. The most frequent topics are Huntington Disease. Dr. Mahmood's most frequent co-authors are Bradley T. Hyman, MD, PhD, Herminia Diana Rosas, MD and Neil Aronin, MD.

CMS Open Payments shows 471 general payments to Dr. Mahmood from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Eli Lilly and Company paid the most, $1,631.

Dmand AI lists 2 awards for Dr. Mahmood, most recently CMS Stage 1 EHR in 2013.

Dr. Mahmood graduated from Rawalpindi Medical College in 1999.

Dr. Mahmood is in network with 11 carriers, including Excellus BlueCross BlueShield, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.